EVOK News and Press, Evoke Pharma Inc. From 05/14/21

SOLANA BEACH, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the appointment of Vickie Reed to the Company’s board of directors. After serving for...

Gainers: MultiPlan (MPLN) +17%, Trinity Biotech (TRIB) +15%, Acutus Medical (AFIB) +11%, Novan (NOVN) +8%, Salarius Pharmaceuticals (SLRX) +7%.Losers: Evoke Pharma (EVOK) -17%, Curis (CRIS) -16%, UroGen Pharma (URGN) -16%, Eargo (EAR...

Evoke Pharma, Inc. (EVOK) Q1 2021 Earnings Conference Call May 12, 2021, 16:30 ET Company Participants Christine Petraglia - The Ruth Group David Gonyer - Co-Founder, CEO, President & Director Christopher Quesenberry - Chief Commercial Officer, Gimoti Matthew D'Onofrio - Co-Founder, Chief...

Evoke Pharma (EVOK): Q1 GAAP EPS of -$0.08 misses by $0.01.Revenue of $0.09M misses by $0.18M.Shares -7.8%.Press Release For further details see: Evoke Pharma EPS misses by $0.01, misses on revenue

Nearly 293% growth of product sales, 235% growth of prescriptions and 87% increase in new prescribers for Gimoti ® New notice of allowance from USPTO to expand Gimoti patent estate SOLANA BEACH, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ...

SOLANA BEACH, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its first quarter 2021 financial resu...

Gainers: Clover Health Investments (CLOV) +20%, Harrow Health (HROW) +12%, Brooklyn ImmunoTherapeutics (BTX) +8%, Evoke Pharma (EVOK) +8%, F-star Therapeutics (FSTX) +7%.Losers: Editas Medicine (EDIT) -15%, Timber Pharmaceuticals (TMBR) -...

Evoke Pharma (EVOK) announces that the United States Patent and Trademark Office ((USPTO)) issued a Notice of Allowance  for U.S. Application No. 16/181,841 for Gimoti (metoclopramide) nasal spray.The patent will cover methods of use for nasal delivery of metoclopramide fo...

SOLANA BEACH, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance to...

SOLANA BEACH, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a commercial stage specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that Yale Jen, Senior Biotech Analyst at Laidlaw & Comp...